Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01822171 · ClinicalTrials.gov registry record · NA
Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients
A NA study, sponsored by Providence Health & Services.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01822171 is a NA study that was terminated before completion, run by Providence Health & Services. The registered enrollment target is 1 participants.
The verdict
NCT01822171, a NA study, was terminated before completion, sponsored by Providence Health & Services.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Readmission to a hospital shortly after discharge is a common and costly problem. In the United States patients with a diagnosis of heart failure currently experience an elevated 30 day readmission rate of approximately 20%. By providing patients with medication related counseling at discharge by a pharmacist, home medications at discharge, and seeing the patient again in a pharmacist-run Medication Therapy Management (MTM) clinic 7 days after discharge, the study anticipates achieving its primary goal of showing a reduction in the readmission rate. Secondary goals are: 1) to determine patients understanding of the medication they are taking, 2) to evaluate satisfaction with the comprehensive discharge counseling service, and 3) determine the number of interventions made and benefit of the MTM clinic.
Interventions
- OTHER Discharge medication counseling from a pharmacist
- OTHER Home medication if needed
- OTHER Follow-up visit at Medication Therapy Management clinic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01822171
The ClinicalTrials.gov registry entry for NCT01822171 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Providence Health & Services, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Discharge medication counseling from a pharmacist is the first listed.
NCT01822171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01822171 about?
NCT01822171 is a clinical study titled "Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients". Readmission to a hospital shortly after discharge is a common and costly problem. In the United States patients with a diagnosis of heart failure currently experience an elevated 30 day readmission rate of approximately 20%. By providing patients with medication related counseling at discharge by a ...
What is the current status of trial NCT01822171?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2013-01. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01822171?
The interventions under investigation include: Discharge medication counseling from a pharmacist (OTHER), Home medication if needed (OTHER), Follow-up visit at Medication Therapy Management clinic (OTHER).
Who is sponsoring clinical trial NCT01822171?
This trial is sponsored by Providence Health & Services, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.